Location |
Greater omentum |
Mesenteric, mediastinal gonadal, and pericardial fat (19, 24, 25) |
|
Size |
349–756 µm in diameter in humans (26). 850 µm in diameter in healthy rabbits (27) |
100–500 µm in diameter in mice (19). Size tends to increase with age (28) |
|
Cell composition |
Macrophages (47.5%) |
B lymphocytes |
B lymphocytes (29.1%) |
T lymphocytes |
T lymphocytes (11.7%) |
Macrophages |
Mast cells (6.1%) (26) |
|
Type 2 innate lymphoid cells (ILC2) (19) |
ILC2 (20–40%) (19) |
CXCL13+ and FDCM1+ stromal cells (29, 30) |
CXCL13+ stromal cells (24) |
|
Developmental requirements |
MS develop independently of ILC3/LTi cells and the chemokines CCL19 and CCL21. On the other hand, MS are defective or absent in Cxcl13−/− and Ltα−/− mice (30) |
FALCs develop independently of ILC3/LTi cells and LTβR signaling. In contrast, their development is dependent on TNF signaling on stromal cells. IL-4R signaling and the presence of invariant natural killer T cells are also required. The requirement for type 2 ILCs in FALC development remains to be investigated (24) |
|
Ontogeny |
Accumulation of myeloid cells in the greater omentum has been observed at 20 weeks of gestation. True MS are observed at 35 weeks of gestation in humans (31) |
Mesenteric FALCs are formed after birth, with visible clusters at 2–3 weeks of age in mice (24) |